Related Experiment Video

Updated: Oct 13, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[The effects of statins on stroke and cardiovascular incidence in randomized, placebo-controlled trials with clinical

L Márk1, A Katona

  • 1II. Belgyógyászat-Kardiológia, Békés Megyei Képviselótestület Pándy Kálmán Kórház, Gyula.

Orvosi Hetilap
|August 16, 2000
PubMed

Insights

Statins significantly reduce stroke incidence, offering benefits beyond cholesterol reduction. These findings suggest increased clinical use of statins for stroke prevention.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Context:

  • Stroke is the third leading cause of death globally, with risk factors overlapping those of coronary heart disease.
  • While some studies show weak correlation between cholesterol and stroke, others indicate a link between high cholesterol and non-hemorrhagic stroke.
  • Large-scale statin trials have demonstrated a reduction in both coronary events and stroke incidence.

Purpose:

  • To analyze the impact of statin therapy on stroke incidence.
  • To explore potential mechanisms of statin action on stroke, including cholesterol-lowering and pleiotropic effects.
  • To evaluate the clinical implications of statin use in reducing stroke events.

Summary:

  • Meta-analyses show varying correlations between cholesterol and stroke risk.
  • Statin trials reveal significant reductions in stroke incidence alongside decreased coronary events.
  • Potential mechanisms include cholesterol reduction, plaque stabilization, improved endothelial function, antithrombotic properties, and vascular tone effects.

Impact:

  • Statin therapy demonstrates a notable decrease in stroke incidence (10-31%) and coronary events (24-34%).
  • The findings support the more frequent use of statins in clinical practice for comprehensive cardiovascular risk management.
  • Further research into the specific mechanisms of statins' effects on stroke is warranted.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...